Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
A look at recent items of interest to you and your practice.
Features
A look at legal reforms that are and are not reducing med-mal lawsuits.
The Third Circuit has determined that, when a patent-holding drug manufacturer makes payments to potential generic competitors to keep them out of the marketplace, that fact alone serves as <i>prima facie</i> evidence of violation of U.S. antitrust laws.
Proctoring by experienced surgeons is a common and increasingly frequent method to credential surgeons for hospital privileges or those who are new to laproscopic or robotic procedures. But what are the legal pitfalls?
Features
Several items of interest to the med mal practitioner.
Features
Insights regarding the considerations every trial lawyer must make when assessing the propriety of offering a rebuttal witness or filing a motion to strike such a witness.
Features
Is the commercial marketplace is a suitable arena to obtain insurance coverage, or are there tipping points that drive business away from these markets and into the hospital captives?
